Micro-UltraSound In Cancer - Active Surveillance
Recruiting now · Not applicable
Conditions studied: Prostate Cancer
In brief
This study will compare the two imaging modalities (MRI and micro-ultrasound) during Active Surveillance of prostate cancer (PCa). Progression to clinically significant PCa will be assessed by first taking micro-US targeted samples (while blinded to MRI results), followed by MRI targeted samples, finishing with 12 systematic biopsy cores. The primary goal is to compare microUS to MRI for the detection of ≥GG2 PCa at confirmatory biopsy. This study will also collect blood samples from participants to be used for future biomarker studies.
Key facts
- Study ID
- NCT05558241
- Run by
- University of Alberta
- People needed
- 210
- Starts
- 2022-11-30
- Expected to finish
- 2033-07-30
- Last updated by the study team
- 2026-06-25
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Adult men with Gleason Grade Group 1 prostate cancer managed by active surveillance who require a confirmatory prostate biopsy
You may not qualify if…
- Men who cannot undergo a prostate MRI
- Men who cannot undergo a prostate biopsy
Where it is running
- University of California Los Angeles, Department of Urology — Los Angeles, California, United States (enrolling)
- Kipnes Urology Centre - Kaye Edmonton Clinic — Edmonton, Alberta, Canada (enrolling)
- University of British Columbia — Vancouver, Alberta, Canada (enrolling)
- CIUSSS du Nord-de-L'Ile-De-Montreal — Montreal, Quebec, Canada (enrolling)
- University Hospital Centre Zagreb — Zagreb, Croatia (enrolling)
- Humanitas — Milan, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.